# DELSTRIGO

NDC: 0006-5007
Generic name: doravirine, lamivudine, and tenofovir disoproxil fumarate
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180720

FDA application: NDA210807

## Active ingredients

- DORAVIRINE: 100 mg/1
- LAMIVUDINE: 300 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5007"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5007
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd1e9f84-607a-46d3-b01e-2736018d67b6